Dr. Grierson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Barnes West Dr
# Dv
Saint Louis, MO 63141Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2016 - 2020- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2014 - 2017
Ohio State University College of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers Start of enrollment: 2020 Sep 15
Roles: Contact
- CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer Start of enrollment: 2023 Jun 02
Roles: Contact, Principal Investigator
- CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer Start of enrollment: 2023 Jun 12
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 183 citationsEsophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.Jaffer A Ajani, Thomas A D'Amico, David J Bentrem, David Cooke, Carlos Corvera
Journal of the National Comprehensive Cancer Network. 2023-04-01 - 21 citationsStroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects.Faran Salim Polani, Patrick M. Grierson, Kian-Huat Lim
World Journal of Gastroenterology. 2021-05-14 - 3 citationsCombined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.Ashenafi Bulle, Peng Liu, Kuljeet Seehra, Sapana Bansod, Yali Chen
Nature Communications. 2024-03-20
Press Mentions
A2 Bio Highlights Progress of TmodTM CAR T-cell Clinical ProgramsNovember 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
